Y-mAbs Therapeutics, Inc.

General ticker "YMAB" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $435.4M (TTM average)

Y-mAbs Therapeutics, Inc. follows the US Stock Market performance with the rate: 8.1%.

Estimated limits based on current volatility of 4.0%: low 3.91$, high 4.23$

Factors to consider:

  • Earnings expected soon, date: 2025-05-13 bmo
  • US accounted for 75.2% of revenue in the fiscal year ended 2024-12-31

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [4.24$, 11.59$]
  • 2025-12-31 to 2026-12-31 estimated range: [2.89$, 8.28$]

Financial Metrics affecting the YMAB estimates:

  • Negative: Non-GAAP EPS, $ of -0.67 <= 0.04
  • Negative: Operating cash flow per share per price, % of -3.47 <= 1.79
  • Negative: negative Operating income
  • Positive: Shareholder equity ratio, % of 76.73 > 63.75
  • Negative: negative Net income
  • Positive: Interest expense per share, $ of 0 <= 0
  • Positive: Industry inventory ratio change (median), % of 0 <= 0

Similar symbols

Short-term YMAB quotes

2025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-112025-04-142025-04-152025-04-162025-04-172025-04-212025-04-222025-04-232025-04-242025-04-252025-04-282025-04-292025-04-302025-05-012025-05-022025-05-052025-05-062025-05-072025-05-082025-05-092025-05-123.844.24.44.64.855.25.4
Price $

Long-term YMAB plot with estimates

4681012141618Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026Jan 2027−0.2−0.15−0.1−0.050
YMABS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $65.27MM $84.82MM $87.69MM
Operating Expenses $160.08MM $110.49MM $118.89MM
Operating Income $-94.81MM $-25.67MM $-31.20MM
Non-Operating Income $-0.76MM $4.81MM $1.39MM
R&D Expense $91.57MM $54.22MM $48.99MM
Income(Loss) $-95.57MM $-20.87MM $-29.81MM
Taxes $0.00MM $0.56MM $-0.15MM
Profit(Loss)* $-96.33MM $-21.43MM $-29.67MM
Stockholders Equity $109.22MM $100.98MM $92.00MM
Inventory $6.70MM $5.07MM $7.21MM
Assets $141.46MM $127.87MM $119.90MM
Operating Cash Flow $-75.92MM $-27.23MM $-15.71MM
Investing Cash Flow $0.04MM $0.01MM $0.00MM
Financing Cash Flow $0.08MM $0.10MM $4.31MM
Earnings Per Share** $-2.20 $-0.49 $-0.67

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.